Baskin-Bey ES - Search Results

1

Proteasome inhibition induces hepatic stellate cell apoptosis.

Anan A, Baskin-Bey ES, Bronk SF, Werneburg NW, Shah VH, Gores GJ. Anan A, et al. Hepatology. 2006 Feb;43(2):335-44. doi: 10.1002/hep.21036. Hepatology. 2006. PMID: 16440346

2

Proteasome inhibition attenuates hepatic injury in the bile duct-ligated mouse.

Anan A, Baskin-Bey ES, Isomoto H, Mott JL, Bronk SF, Albrecht JH, Gores GJ. Anan A, et al. Am J Physiol Gastrointest Liver Physiol. 2006 Oct;291(4):G709-16. doi: 10.1152/ajpgi.00126.2006. Epub 2006 Jun 22. Am J Physiol Gastrointest Liver Physiol. 2006. PMID: 16798723 Free article.

3

Constitutive androstane receptor (CAR) ligand, TCPOBOP, attenuates Fas-induced murine liver injury by altering Bcl-2 proteins.

Baskin-Bey ES, Huang W, Ishimura N, Isomoto H, Bronk SF, Braley K, Craig RW, Moore DD, Gores GJ. Baskin-Bey ES, et al. Hepatology. 2006 Jul;44(1):252-62. doi: 10.1002/hep.21236. Hepatology. 2006. PMID: 16799968

4

The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse.

Canbay A, Feldstein A, Baskin-Bey E, Bronk SF, Gores GJ. Canbay A, et al. J Pharmacol Exp Ther. 2004 Mar;308(3):1191-6. doi: 10.1124/jpet.103.060129. Epub 2003 Nov 14. J Pharmacol Exp Ther. 2004. PMID: 14617689

5

Treatment endpoints for advanced cholangiocarcinoma.

Gores GJ, Baskin-Bey ES, Baron TH, Alberts SR. Gores GJ, et al. Nat Clin Pract Gastroenterol Hepatol. 2004 Nov;1(1):4-5. doi: 10.1038/ncpgasthep0008. Nat Clin Pract Gastroenterol Hepatol. 2004. PMID: 16265019 No abstract available.

6

Lack of gp130 expression results in more bacterial infection and higher mortality during chronic cholestasis in mice.

Wuestefeld T, Klein C, Streetz KL, Beraza N, Schölmerich J, Burgart LJ, Zender L, Kubicka S, Baskin-Bey E, Gores GJ, Manns MP, Trautwein C. Wuestefeld T, et al. Hepatology. 2005 Nov;42(5):1082-90. doi: 10.1002/hep.20912. Hepatology. 2005. PMID: 16250046

7

Liver transplantation for gastroenteropancreatic neuroendocrine cancers: Defining selection criteria to improve survival.

van Vilsteren FG, Baskin-Bey ES, Nagorney DM, Sanderson SO, Kremers WK, Rosen CB, Gores GJ, Hobday TJ. van Vilsteren FG, et al. Liver Transpl. 2006 Mar;12(3):448-56. doi: 10.1002/lt.20702. Liver Transpl. 2006. PMID: 16498656 Free article.

8

Caspase-8, death-receptor signaling, and hepatocarcinogenesis: the Fas and the furious.

Baskin-Bey ES, Gores GJ. Baskin-Bey ES, et al. Gastroenterology. 2005 Nov;129(5):1790-2. doi: 10.1053/j.gastro.2005.09.037. Gastroenterology. 2005. PMID: 16285976 No abstract available.

9

Preliminary report of the Hepatic Encephalopathy Assessment Driving Simulator (HEADS) score.

Baskin-Bey ES, Stewart CA, Mitchell MM, Bida JP, Rosenthal TJ, Nyberg SL. Baskin-Bey ES, et al. Ethn Dis. 2008 Summer;18(3):357-64. Ethn Dis. 2008. PMID: 18785452 Clinical Trial.

10

Cytotoxic immune response to a xenogeneic bioartificial liver.

Nyberg SL, Amiot B, Hardin J, Baskin-Bey E, Platt JL. Nyberg SL, et al. Cell Transplant. 2004;13(7-8):783-91. doi: 10.3727/000000004783983378. Cell Transplant. 2004. PMID: 15690980 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters